শুধুমাত্র তথ্যমূলক — চিকিৎসা পরামর্শ নয়। সর্বদা লাইসেন্সপ্রাপ্ত স্বাস্থ্যসেবা প্রদানকারীর পরামর্শ নিন।

MedBD
EN
Community data Updated 2 মাস আগে
🌐 View in English

ইঙ্গিত

Adiva in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection. This indication is based on analyses of plasma HIV- RNA levels and CD4 cell counts in controlled studies of up to 24 weeks in duration. At present, there are no results from controlled trials evaluating long term suppression of HIVRNA with Adiva.

⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।

ফার্মাকোলজি

Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) active against HIV-1. It blocks RNA and DNA dependent polymerase activities, including HIV-1 replication.

Pregnancy & Breastfeeding

Category D: There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).Lactation: Efavirenz may pass through breast milk and cause serious harm to the baby. It should not be used during lactation.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

ডোজ নির্দেশিকা

⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।

Adults: Dosage in Adults: The recommended dose of Efavirenz is 600 mg taken by mouth once daily, combined with a protease inhibitor and/or nucleoside analogue reverse transcriptase inhibitors (NRTIs). Dosage in Pediatric Patients: For children 3 years of age or older weighing between 10 and 40 kg, the recommended dose of Efavirenz depends on body weight. Children weighing 10 to less than 15 kg should receive 200 mg once daily. Those weighing 15 to less than 20 kg should receive 250 mg once daily. Those weighing 20 to less than 25 kg should receive 300 mg once daily. Those weighing 25 to less than 32.5 kg should receive 350 mg once daily. Those weighing 32.5 to less than 40 kg should receive 400 mg once daily. Children weighing 40 kg or more, as well as those weighing more than 40 kg, should receive the same dose used in adults, which is 600 mg once daily.

পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া

পার্শ্বপ্রতিক্রিয়া

No side-effect data recorded yet.